Ibogaine is a drug being tested as a treatment for drug addictions of most types. Patients who have tried it claim that it not only prevents withdrawal but eliminates craving for a period as well. The effects of ibogaine include the re-experiencing of past memories, a property which has interested some psychotherapists, but also the Drug Enforcement Agency (USA) which has placed the drug on Schedule I. Nevertheless, the Food and Drug Administration (USA) has approved human trials which have stalled due to the unavailability of funding.

This document was created to promote the study of ibogaine because it has the potential to alleviate so much suffering.

Bibliography 11/21/97

Aaron, J. J.; Sanders, L. B. and Winefordner, J. D. "Analytical study of some important hallucinogens by a combined fluorimetric and phosphorimetric method.", Clinica Chimica Acta, (1973), 45(4), 375-386.

Abaul, J.; Philogene, E.; Bourgeois, P.; Ahond, A.; Poupat, C. and Potier, P. "Contributions to a study of American Tabernaemontanae. VI. Alkaloids from the leaves of Tabernaemontana citrifolia.", Journal of Natural Products, (1989), 52(6), 1279-1283 (French). PDF (596 KB)

Abraham, H. D.; Aldridge, A. M. and Gogia, P. "The psychopharmacology of hallucinogens.", Neuropsychopharmacology, (1996), 14, 285-298.

Aceto, M. D.; Bowman, E. R.; Harris, L. S. and May, E. L. "Dependence studies of new compounds in the rhesus monkey and mouse (1991).", NIDA Research Monograph, (1992), 119, 513-558. PDF (391 KB)

Aceto, M. D.; Bowman, E. R.; Harris, L. S. and May, E. L. "Dependence studies on new compounds in the rhesus monkey, rat and mouse (1989).", NIDA Research Monograph, (1989), 95, 578-631. PDF (2.9 MB)

Achenbach, Hans and Raffelsberger, Bernd. "Alkaloids in Tabernaemontana species, XI. Investigation of the alkaloids from Tabernaemontana quadrangularis - (20R)-20-hydroxyibogamine, a new alkaloid from T. quadrangularis.", Zeitschrift fur Naturforschung. Teil B: Anorganische Chemie, Organische Chemie, (1980), 35B(2), 219-225 (German). PDF (984 KB)

Achenbach, Hans and Raffelsberger, Bernd. "Alkaloids in Tabernaemontana species, XII. Investigation of the alkaloids from Tabernaemontana olivacea - condylocarpine-N-oxide, a new alkaloid from T. olivacea.", Zeitschrift fur Naturforschung. Teil B: Anorganische Chemie, Organische Chemie, (1980), 35B(7), 885-891 (German). PDF (902 KB)

Adams, Jan Thatcher. "Drug ibogaine offers relief to addicts.", The Edge, (May 1995), 22.

Agwada, V.; Morita, Y.; Renner, U.; Hesse, M. and Schmid, H. "Die Alkaloide von Gabuina eglandulosa Stapf.", Helvetica Chimica Acta, (1975), 58(4), 1001-1016 (German). PDF (3.8 MB)

Ahmad, Yusuf; Le Quesne, P. W. and Neuss, N. "The structure of sewarine, an indole alkaloid from Rhazya stricta.", Journal of the Chemical Society. D, Chemical Communications, (1970), 9, 538-539. PDF (258 KB)

Alburges, M. E.; Foltz, R. L. and Moody, D. E. "Determination of ibogaine and 12-hydroxyibogamine in plasma by gas chromatography positive ion chemical ionization mass spectrometry.", Journal of Analytical Toxicology, (October 1995), 19(6), 381-386.

Ali, S. F.; Newport, G. D.; Slikker, W. Jr.; Rothman, R. B. and Baumann, M. H. "Neuroendocrine and neurochemical effects of acute ibogaine administration - a time course evaluation.", Brain Research, (1996), 737(1-2), 215-220.

Ali, S. F.; Chetty, S. C.; Meng, X. M.; Newport, G. D. and Slikker, W. "A single injection of ibogaine produces selective neurochemical changes in mouse brain.", Journal of Neurochemistry, (1995), 65, S172. PDF (164 KB)

Allen, M. J. and Powell, V. J. "Anodic polarography with a rotating platinum microelectrode. II. Oxidation of various indole alkaloids.", Journal of the Electrochemical Society, (1958), 105, 541-544.

Allorge, P.; Boiteau, P.; Bruneton, J.; Stevenet, T. and Cave, A. "Etude botanique et chimique comparee de quatre especes souvent confondues sous le nom d'Ervatamia orientalis (Apocynacees).", Journal of Natural Products, (1980), 43(4), 514-523 (French). PDF (1.7 MB)

Alper, K. R.; Lotsof, H. S. and Kaplan, C. D. "The ibogaine medical subculture", Journal of Ethnopharmacology, (2008), 115, 9-24. PDF (350 KB)

Annonymous. PharmChem Newsletter, (1972), 1(2), 3-4.

Anonymous. "Conditions for investigational use of hallucinogenic drugs bufotenine, N,N-diethyltryptamine, and ibogaine and their salts.", Federal Register, (January 31, 1968), 33, 2384.

Anonymous. "Depressant and stimulant drugs. Listing of additional drugs as drugs subject to control.", Federal Register, (September 23, 1967), 32, 13407-13408.

Arai, Gerda; Coppola, J. and Jeffrey, G. A. "The structure of ibogaine.", Acta Crystallographica, (1960), 13, 553-564.

Aries, Robert. "Doping control in race horses.", Belgian patent, (September 16, 1965), 664,377.

Atta-ur-Rahman; Fatima, T.; Crank, George and Wasti, Shaheen. "Alkaloids from Trachelospermum jasminoides.", Planta Medica, (1988), 54(4), 364. PDF (129 KB)

Augustine, R. L. "Synthesis of iboga alkaloids and related compounds.", Psychopharmacology Bulletin, (April 1969), 5(2), 18.

Badio, Barbara; Padgett, William L. and Daly, John W. "Ibogaine: A potent noncompetitive blocker of ganglionic/neuronal nicotinic receptors.", Molecular Pharmacology, (1997), 51(1), 1-5. PDF (608 KB)

Bagal, A. A.; Hough, L. B.; Nalwalk, J. W. and Glick, S. D. "Modulation of morphine-induced antinociception by ibogaine and noribogaine.", Brain Research, (1996), 741(1-2), 258-262.

Bartlett, M. F.; Dickel, D. F. and Taylor, W. I. "The structures of ibogamine, ibogaine, tabernanthine, and voacangine.", Journal of the American Chemical Society, (1958), 80, 126-136.

Barrass, B. C. and Coult, D. B. "Interaction of some centrally active drugs with ceruloplasmin.", Biochemical Pharmacology, (1972), 21(5), 677-685

Barrass, B. C. and Coult, D. B. "Effects of some centrally acting drugs on ceruloplasmin.", Progress in Brain Research, (1972), 36, 97-104.

Basile, D. V.; Punch, M. S.; Pablo, J.; Brenner, B.; Hearn, W. L. and Mash, D. C. "Indole alkaloids from tissue-cultured Tabernanthe iboga H. Bn.", Natural Product Letters, (1999), 13(3), 233-238. PDF (483 KB)

Batchily, F.; Mehri, H. and Plat, M. "Alkaloids from the seeds of Sarcopharyngia crassa (Benth.) Boiteau et Allorge.", Annales Pharmaceutiques Francaises, (1986), 44(6), 449-454 (French).

Benwell, Maureen E. M.; Holtom, Pamela E.; Moran, Robert J. and Balfour, David J. K. "Neurochemical and behavioural interactions between ibogaine and nicotine in the rat.", British Journal of Pharmacology, (February 1996), 117(4), 743-749. PDF (896 KB)

Bert, M. et al. "Alkaloids of Pagiantha cerifera.", Fitoterapia, (1989), 60(2), 141-146.

Bert, Maryse; Marcy, Rene; Quermonne, Marie-Anne; Cotelle, Michel and Koch, Michel "Non-amphetaminic central stimulation by alkaloids from the ibogaine and vobasine series.", Planta Medica, (June 1988), 54(3), 191-192. PDF (256 KB)

Bertol, Elisabetta; Mari, Francesco and Froldi, Rino "[Detection of ibogaine in organic liquids.]", Journal of Chromatography, (February 4, 1976), 117(1), 239-241 (French). PDF (362 KB)

Bhargava, H. N.; Cao, Y. J. and Zhao, G. M. "Effects of ibogaine and noribogaine on the antinociceptive action of mu-, delta- and kappa-opioid receptor agonists in mice.", Brain Research, (March 28, 1997), 752(1-2), 234-238.

Biemann, K. and Friedmann-Spiteller, Margot. "Application of mass spectrometry to structure problems. V. Iboga alkaloids.", Journal of the American Chemical Society, (1961), 83, 4805-4810.

Biemann, K. and Friedmann-Spiteller, Margot. "Mass spectrometric evidence for the structure of iboxygaine and its tosylate.", Tetrahedron Letters, (1961), 2, 68-71.

Biemann, K. "Determination of the carbon skeleton of sarpagine by mass spectrometry.", Tetrahedron Letters, (1960), 15, 9-14.

Blaha, K.; Koblicova, Z. and Trojanek, J. "Alkaloids. XXX. Chiroptical investigations on the iboga and voacanga alkaloids.", Collection of Czechoslovak Chemical Communications, (1974), 39(8), 2258-2266.

Blaha, K.; Koblicova, Z. and Trojanek, J. "Absolute configuration of the Iboga and Voacanga alkaloids. Chiroptical approach.", Tetrahedron Letters, (1972), 27, 2763-2766.

Blakeslee, Sandra. "Bizarre drug holds hope for addicts.", New York Times, (Wednesday, October 27, 1993), v143:B7(N), pC11(L).

Bocher, Dominique and Naranjo, Claudio. "Psychopharmaceuticals.", German patent, (September 4, 1969), 1,902,227 (German).

Bowen, W. D.; Vilner, B. J.; Williams, W.; Bertha, C. M.; Kuehne, M. E. and Jacobson, A. E. "Ibogaine and its congeners are sigma(2) receptor-selective ligands with moderate affinity.", European Journal of Pharmacology, (June 6, 1995), 279(1), R1-R3.

Brailowsky, Simon; Walter, Stephane; Vuillon-Cacciuttolo, Ghislaine and Serbanescu, Tudor. "[Tremorogenic and nontremorogenic indole alkaloids: effects on photosensitive epilepsy in Papio papio.]", Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales, (Volume date 1975), 169(5), 1190-1193 (French).

Broderick, Patricia A.; Phelan, Frank T.; Eng, Frank and Wechsler, Robert T. "Ibogaine modulates cocaine responses which are altered due to environmental habituation: in vivo microvoltammetric and behavioral studies.", Pharmacology Biochemistry and Behavior, (1994), 49(3), 711-728. PDF (2.6 MB)

Broderick, P. A.; Phelan, F. T. and Berger, S. P. "Ibogaine alters cocaine induced biogenic amine and psychostimulant dysfunction but not [3H] GBR-12935 binding to the dopamine transporter protein", NIDA Research Monograph, (1992), 119, 285.

Bruneton, J.; Sevenet, T. and Cave, A. "Plantes de Novelle Caledonie, 66. Alcaloides d'Ervatamia lifuana.", Planta Medica, (1980), 39, 180-182 (French). PDF (591 KB)

Bruneton, J.; Bouquet, A. and Cave, A. "Alkaloids from Daturicarpa elliptica Stapf.", Plant Medicine and Phytotherapy, (1976), 10(1), 20-23 (French).

Brustier, Vincent; Vincent, Daniel and Sero, Irene. "The ultraviolet absorption spectrum of ibogaine.", Comptes Rendus, (1943), 216, 909-911.

Buchi, G.; Coffen, D. L.; Kocsis, Karoly; Sonnet, P. E. and Ziegler, Frederick E. "The total synthesis of Iboga alkaloids.", Journal of the American Chemical Society, (1966), 88(13), 3099-3109. PDF (2.1 MB)

Buchi, G. and Manning, R. E. "Chemical transformations of ibogaine.", Journal of the American Chemical Society, (1966), 88(11), 2532-2535. PDF (703 KB)

Bui, A-M.; Debray, M-M.; Boiteau, P. and Potier, P. "Etude chimiotaxonomique de quelques especes de Hazunta.", Phytochemistry, (1977), 16, 703-706 (French). PDF (426 KB)

Bunag, Ruben D. and Walaszek, E. J. "Cardiovascular-effects of substance P in the chicken.", Annals of the New York Academy of Sciences, (1963), 104 (Article 1), 437-448.

Cao, Y. J. and Bhargava, H. N. "Effects of ibogaine on the development of tolerance to antinociceptive action of mu-, delta- and kappa-opioid receptor agonists in mice.", Brain Research, (March 28, 1997), 752(1-2), 250-254.

Cappendijk, S. L. T.; Fekkes, D. and Dzoljic, M. R. "Norharman - endogenous inhibitor of morphine withdrawal.", Regulatory Peptides, (1994), 54(1), 39-40. PDF (333 KB)

Cappendijk, Susanne L. T.; Fekkes, Durk and Dzoljic, Michailo R. "The inhibitory effect of norharman on morphine withdrawal syndrome in rats: comparison with ibogaine.", Behavioural Brain Research, (1994), 65, 117-119. PDF (377 KB)

Cappendijk, S. L. T. and Dzoljic, M. R. "Inhibitory effects of ibogaine on cocaine self-administration in rats.", European Journal of Pharmacology, (1993), 241, 261-265.

Carrera, I. et al. "Efficient Access to the Iboga Skeleton: Optimized Procedure to Obtain Voacangine from Voacanga africana Root Bark", ACS Omega (2021), 6, 16755-16762. PDF (1.9 MB)

Carroll, P. R. and Starmer, G. A. "Studies on the pharmacology of conopharyngine, an indole alkaloid of the voacanga series.", Br. J. Pharmac. Chemother. (1967), 30, 173-185. PDF (1.7 MB)

Cartoni, G. Paolo and Giarusso, Alberto "Gas chromatographic determination of ibogaine in biological fluids.", Journal of Chromatography, (August 23, 1972), 71(1), 154-158. PDF (611 KB)

Cava, M.; Watanabe, Y.; Bessho, K.; Weisbach, J. and Douglas, B. "The alkaloids of Tabernaemontana crassa.", The Journal of Organic Chemistry, (1968), 33(8), 3350-3352. PDF (1.2 MB)

Cava, M.; Talapatra, S.; Weisbach, J.; Douglas, B.; Raffauf, R. and Beal, J. "Gabunine: A natural dimeric indole derived from perivine.", Tetrahedron Letters, (1965), 14, 391-395. PDF (541 KB)

Cavallaro, Aldo and Elli, Giuseppe. "Thin-layer electrophoresis of hallucinogenic substances.", Bollettino dei Laboratori Chimici Provinciali, (1972), 23(1), 27-32 (Italian).

Chen, K.; Kokate, T. G.; Donevan, S. D.; Carroll, F. I. and Rogawski, M. A. "Ibogaine block of the NMDA receptor - in vitro and in vivo studies.", Neuropharmacology, (1996), 35(4), 423-431.

Chen, Graham and Bohner, Barbara. "A study of central nervous system stimulants.", Journal of Pharmacology and Experimental Therapeutics, (1958), 123(3), 212-215.

Clivio, Pascale; Richard, Bernard; Deverre, Jean-Robert; Sevenet, Thierry; Zeches, Monique and Le Men-Oliver, Louisette. "Alkaloids from leaves and root bark of Ervatamia hirta.", Phytochemistry, (1991), 30(11), 3785-3792. PDF (1.3 MB)

Codd, Ellen E. "High affinity ibogaine binding to a MU opioid agonist site.", Life Sciences, (October 6, 1995), 57(20), PL315-PL320.

Cordier, P. "Generalities on the structure of azepine compounds used in drug therapy.", Bulletin de la Societe de Pharmacie de Strasbourg, (1971), 14(1), 9-23 (French).

Cowley, Geoffrey. "A psychedelic trip to the end of addiction. (Health: Can a tribal potion block cravings?)", Newsweek, (August 23, 1993), 122(8), 45.

Crooks, P. and Robinson, B. "Conopharyngine pseudoindoxyl, a new alkaloid from Tabernaemontana pachysiphon Stapf var. cumminsii (Stapf.) H. Huber.", Journal of Pharmacy and Pharmacology, (1973), 25, 820-823. PDF (672 KB)

Dagnino, Denise; Schripsema, Jan; Peltenburg, Anja; Verpoorte, Robert and Teunis, Kees. "Capillary gas chromatographic analysis of indole alkaloids: investigation of the indole alkaloids present in Tabernaemontana divaricata cell suspension culture.", Journal of Natural Products, (1991), 54(6), 1558-1563. PDF (870 KB)

Damak, Mohamed; Poupat, Christiane and Ahond, Alain. "Bis-12-[11-hydroxycoronaridinyl], a new dimeric alkaloid of the ibogane type. Structure elucidation by carbon-13 NMR.", Tetrahedron Letters, (1976), 39, 3531-3534 (French). PDF (913 KB)

De Rienzo, Paul; Beal, Dana and others. "The Ibogaine Story, Report on the Staten Island Project.", Autonomedia: POB 568 Williamsburgh Station, Brooklyn, New York 11211-0568 USA, (1997), 352 p.

De Zorzi, Claudio and Cutrona, Carolina. "Hallucinogenic drugs. Chemicopharmacological, social, and juridical aspects.", Zacchia, (1973), 8(3), 359-434 (Italian).

Deecher, Darlene C.; Teitler, Milton; Soderlund, David M.; Bornmann, William G.; Kuehne, Martin E. and Glick, Stanley D. "Mechanisms of action of ibogaine and harmaline congeners based on radioligand binding studies.", Brain Research, (1992), 571, 242-247. PDF (677 KB)

Delourme-Houde, M. Jean. "Study of iboga (Tabernanthe iboga H. Bn.).", Annales Pharmaceutiques Francaises, (1946), 4, 30-36 (French). PDF (846 KB)

Denolin-Dewaersegger, L. and van Binst, G. "Effect of solvent on the O-H and N-H stretching frequencies of some alcohols and amines.", Bulletin des Societes Chimiques Belges, (1962), 71, 615-622.

Depoortere, H. "Neocortical rhythmic slow activity during wakefulness and paradoxical sleep in rats.", Neuropsychobiology, (1987), 18, 160-168. PDF (1.5 MB)

Depoortere, H.; Leonardon, J. and Jalfre, M. "The influence of some pharmacological agents on the duration of sodium .gamma.-hydroxybutyrate-induced 'sleep' in curarized rats.", Proceedings of the European Congress on Sleep Research, 3rd, (Meeting Date 1976), 370-372.

Deus-Neumann, B.; Stoeckigt, J. and Zenk, M. H. "Radioimmunoassay for the quantitative determination of catharanthine.", Planta Medica, (1987), 53(2), 184-188.

Dhahir, H. I.; Jain, Naresh C. and Thornton, John I. "The identification of ibogaine in biological material.", Journal - Forensic Science Society, (January 1972), 12(1), 309-313. PDF (764 KB)

Dhahir, Hashim I. "Comparative study on the toxicity of ibogaine and serotonin.", Dissertation Abstracts International. B, Science and Engineering., (1971), 32(4), 2311-2312.

Dhahir, H. I.; Jain, N. C. and Forney, R. B. "Methods for the detection and determination of ibogaine in biological materials.", Journal of Forensic Sciences, (January 1971), 16(1), 103-108. PDF (760 KB)

Diamond, Nina L. "Ibogaine II: down memory lane; Does one trip equal 30 years on a therapist's couch?", Omni, (February 1994), 16(5), 16.

Dickel, D. F.; Holden, C. L.; Maxfield, R. C.; Paszek, L. E. and Taylor, W. I. "The alkaloids of Tabernanthe iboga. Part III. Isolation studies.", Journal of the American Chemical Society, (1958), 80, 123-125.TEXT (18 KB)

Doblin, Rick. "NIDA to Fund Ibogain Studies.", Psychedelic Illuminations, volume 6, (1994?), 9-11.

Duc, Do Khac Manh and Fetizon, Marcel. "[Synthesis of ibogaine analogs.]", Bulletin de la Societe Chimique de France, (1969), 11, 4154-4159 (French). PDF (898 KB)

Duc, Do Khac Manh and Fetizon, Marcel. "[Synthesis of an ibogaine analog.]", Bulletin de la Societe Chimique de France, (1966), 2, 771-772 (French). PDF (302 KB)

Dugan, J.; Hesse, M.; Renner, U. and Schmid, H. "Conoflorin.", Helvetica Chimica Acta, (1967), 50(1), 60-67 (German). PDF (585 KB)

Dworkin, Steven I.; Gleeson, Suzanne; Meloni, Domenico; Koves, Timothy R. and Martin, Thomas J. "Effects of ibogaine on responding maintained by food, cocaine and heroin reinforcement in rats.", Psychopharmacology, (February 1995), 117(3), 257-261. PDF (673 KB)

Dzoljic, E. D.; Kaplan, C. D. and Dzoljic, M. R. "Effect of ibogaine on naloxone-precepitated withdrawal syndrome in chronic morphine-dependent rats.", Archive of International Pharmacodynamics, (1988), 294, 64-70. PDF (687 KB)

Epstein, Joseph William and Goldman, Leon. "Acyl derivatives of 10-methoxyibogamine.", Unites States patent, (February 6, 1973), 3,715,361. PDF (337 KB)

Fares, Fares A. and Jankowski, Christopher K. "Gif(IV) oxidation of some indolic alkaloids.", Heterocycles, (1992), 34(11), 2109-2115. PDF (724 KB)

Farnsworth, Norman R. "Hallucinogenic plants: various chemical substances are known to be the active hallucinogenic principles in many plants.", Science, (1968), 162, 1086-1092.

Fernandez, J. W. "Bwiti: An Ethnography of the Religious Imagination of Africa.", Princeton University Press, Princeton, NJ, (1982).

Fernandez, J. W. "Tabernanthe iboga: Narcotic ecstasis and the work of the ancestors", Flesh of the Gods: The Ritual Use of Hallucinogens, Furst, P. T. Ed: Praeger, New York, (1972), 237-260.

Fiorese, F.; Vermuelen, G. and Turcotte, C. "Ferric chloride/hydrogen chloride/potassium iodide versatile wide application reagent.", Substance and Alcohol Actions/Misuse, (1982), 3(1-2), 47-59.

Fiorese, F.; Vermeulen, G. and Turcotte, C. "Ferric chloride/hydrogen chloride/potassium chloride versatile wide application reagent.", Toxicological Aspects, [International Congress of the European Association of Poison Control Centers], (1980), 9th, 431-445.

Fonne-Pfister, Raymonde and Meyer, Urs A. "Xenobiotic and endobiotic inhibitors of cytochrome P-450dbl function, the target of the debrisoquine/sparteine type polymorphism.", Biochemical Pharmacology, (1988), 37(20), 3829-3835.

Fox, Nicols. "Iboga? Frog calls? It's community radio.", Washington Journalism Review, (October 1991), 13(8), 15.

Frances, B.; Gout, R.; Cros, J. and Zajac, J. M. "Effects of ibogaine on naloxone-precipitated withdrawal in morphine-dependent mice.", Fundamental & Clinical Pharmacology, (1992), 6(8-9), 327-332.

French, E. D.; Dillon, K. and Ali, S. F. "Effects of ibogaine, and cocaine and morphine after ibogaine, on ventral tegmental dopamine neurons.", Life Sciences, (1996), 59(12), PL199-PL205.

Furst, P. T. "Los Alucinogenos y la Cultura." Fondo de Cultura Economica, Mexico City (1980), (Spanish).

Furst, P. T. "Hallucinogens and Culture.", Chandler & Sharp, Novato, CA, (1976).

Gaignault, J. C. and Delourme-Houde, J. "Les alcaloides de l'iboga.", Fitoterapia, (1977), 48, 243-265 (French).

Gallagher, Carol A.; Hough, Lindsay B.; Keefner, Sandra M.; Seyed-Mozaffari, Ahmad; Archer, Sydney and Glick, Stanley D. "Identification and quantification of the indole alkaloid ibogaine in biological samples by gas chromatography-mass spectrometry.", Biochemical Pharmacology, (January 6, 1995), 49(1), 73-79. PDF (597 KB)

Geigy, J. R. "Decarboxylation of alkyl esters of nitrogen-containing unsaturated acids.", Swiss patent, (November 30, 1963), 372,291.

Geigy, J. R. "Decarboxylation of the indole group ester alkaloids.", German patent, (July 5, 1962), 1,132,561.

Gershon, S. and Bell, C. "A study of the antagonism of some indole alkaloids to the behavior effects of Ditran.", Medicina Experimentalis, (1963), 8, 15-27.

Gershon, S. and Lang, W. J. "A psycho-pharmacological study of some indole alkaloids.", Archives Internationales de Pharmacodynamie, (1962), 135(1-2), 31-56. PDF (1.9 MB)

Ghorbel, N. and Damak, M. "Contribution a l'etude des Tabernaemontanees americaines. IV. Alcaliodes de Peschiera echinata.", Journal of Natural Products, (1981), 44, 717-721 (French). PDF (542 KB)

Glick, Stanley D.; Maisonneuve, Isabelle M. and Pearl, Sandra M. "Evidence for roles of kappa-opioid and NMDA receptors in the mechanism of action of ibogaine.", Brain Research, (1997), 749(2), 340-343. PDF (482 KB)

Glick, S. D.; Kuehne, M. E.; Maisonneuve, I. M.; Bandarage, U. K. and Molinari, H. H. "18-Methoxycoronaridine, a non-toxic iboga alkaloid congener: effects on morphine and cocaine self-administration and on mesolimbic dopamine release in rats.", Brain Research, (1996), 719(1-2), 29-35. PDF (1.1 MB)

Glick, S. D.; Pearl, S. M.; Cai, J. and Maisonneuve, I. M. "Ibogaine-like effects of noribogaine in rats.", Brain Research, (March 25, 1996), 713(1-2), 294-297. PDF (468 KB)

Glick, S. D.; Kuehne, M. E.; Raucci, J.; Wilson, T. E.; Larson, E.; Keller, Jr. R. W. and Carlson, J. N. "Effects of iboga alkaloids on morphine and cocaine self-administration in rats: relationship to tremorgenic effects and to effects on dopamine release in nucleus accumbens and striatum.", Brain Research, (1994), 657, 14-22.

Glick, S. D.; Rossman, K.; Wang, S.; Dong, N. and Keller, R. W. Jr. "Local effects of ibogaine on extracellular levels of dopamine and its metabolites in nucleus accumbens and striatum: interactions with D-amphetamine.", Brain Research, (November 19, 1993), 628(1-2), 201-208. PDF (874 KB)

Glick, S. D.; Rossman, K.; Rao, N. C.; Maisonneuve, I. M. and Carlson, J. N. "Effects of ibogaine on acute signs of morphine withdrawal in rats: independence from tremor.", Neuropharmacology, (1992), 31(5), 497-500.

Glick, Stanley D.; Gallagher, Carol A.; Hough, Lindsay B.; Rossman, Kent L. and Maisonneuve, Isabelle M. "Differential effects of ibogaine pretreatment on brain levels of morphine and (+)-amphetamine.", Brain Research, (1992), 588, 173-176. PDF (434 KB)

Glick, S. D.; Rossman, K.; Steindorf, S.; Maisonneuve, I. M. and Carlson, J. N. "Effects and aftereffects of ibogaine on morphine self-administration in rats.", European Journal of Pharmacology, (1991), 195, 341-345. PDF (546 KB)

Goldblatt, A.; Hootele, C. and Pecher, J. "The alkaloids of Voacanga thouarsii var. Obtusa.", Phytochemistry, (1970), 9(6), 1293-1298. PDF (929 KB)

Gollnhofer, O. and Sillans, R. "Usages rituels de l'iboga au Gabon [Ritual uses of iboga in Gabon].", Psychotropes, (1985), 2(3), 95-108 (French).

Gollnhofer, O. and Sillans, R. "L'iboga psychotrope Africain [Iboga, an African psychotropic agent].", Psychotropes, (1983), 1(1), 11-27 (French).

Gorman, M.; Neuss, N.; Cone, N. and Deyrup, J. "Alkaloids from Apocynacea. III. Alkaloids of Tabernaemontana and Ervatamia. The structure of coronaridine, a new alkaloid related to ibogamine.", Journal of the American Chemical Society, (1960), 82, 1142-1145. PDF (1.7 MB)

Goutarel, R.; Janot, M.-M.; Mathys, F. and Prelog, V. "Uber das Ibolutein.", Helvetica Chimica Acta, (1956), 39, 742-748 (German). PDF (678 KB)

Goutarel, R.; Gollnhofer, O. and Sillans, R. "Pharmacodynamics and therapeutic applications of iboga and ibogaine.", Psychedelic Monographs and Essays, (1993), 6, 71-111.

Goutarel, R.; Gollnhofer, O. and Sillans, R. "L'iboga contre la dependence aux stupefiants pharmacodynamie et applications psychotherapeautiques.", Psychotropes, (1993), 3(3), 63-86 (French).

Goutarel, R.; Poisson, J.; Croquelois, G.; Rolland, Y. and Miet, C. "[Constituents of seeds of Tabernanthe iboga Baillon. I. Alkaloids].", Annales Pharmaceutiques Francaises, (September-October 1974), 32(9-10), 521-524 (French). PDF (396 KB)

Goutarel, R.; Percheron, F.; Wohlfahrt, J. and Janot, M. M. "Structure of the alkaloids of iboga.", Annales Pharmaceutiques Francaises, (1957), 15, 353-360.

Goutarel, Robert; Janot, Maurice Marie; Mathys, Frederic and Prelog, Vlado. "Structure of ibogaine.", Comptes Rendus, (1953), 237, 1718-1720.

Gui, Liu; Xin, Liu and Xiao-zhang, Feng. "Ervayunine: A new indole alkaloid from Ervatamia yunnanensis.", Planta Medica, (1988), 54(6), 519-521. PDF (293 KB)

Haller, A. and Heckel, Ed. "Sur l'ibogine, principe actif d'une plante du genre Tabernaemontana, originaire du Congo.", Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences, (1901), 133, 850-853 (French). PDF (545 KB)

Harmouche, A.; Mehri, H.; Koch, M.; Rabaron, A.; Plat, M. and Sevenet, T. "Plants of New Caledonia. XXXIX. Alkaloids from leaves of Pagiantha cerifera Mkgf. (Apocynaceae).", Annales Pharmaceutiques Francaises, (1976), 34(1-2), 31-35 (French).

Harsing, L. G. Jr.; Sershen, H. and Lajtha, A. J. "Evidence that ibogaine releases dopamine from the cytoplasmic pool in isolated mouse striatum.", Journal of Neural Transmission, (1994), 96, 215-225.

Hearn, W. L.; Pablo, J.; Hime, G. W. and Mash, D. C. "Identification and quantification of ibogaine and O-demethylated metabolite in brain and biological fluids using gas chromatography mass spectrometry.", Journal of Analytical Toxicology, (October 1995), 19(6), 427-434.

Hedberg, Inga; Hedberg, Olov; Madati, Posanyi J.; Mshigeni, Keto E.; Mshiu, E. N. and Samuelsson, Gunnar. "Inventory of plants used in traditional medicine in Tanzania. I. Plants of the families Acanthaceae-Cucurbitaceae.", Journal of Ethnopharmacology, (1982), 6(1), 29-60. PDF (2.6 MB)

Heggenhougen, H. Kris. "Reaching new highs: Alternative therapies for drug addicts.", Jason Aronson, Inc, Northvale, NJ, USA, (1997), 208 pp.

Helsley, S.; Fiorella, D.; Rabin, R. A. and Winter, J. C. "Effects of ibogaine on performance in the 8-arm radial maze.", Pharmacology, Biochemistry and Behavior, (1997), 58(1), 37-41. PDF (480 KB)

Helsley, S.; Dlugos, C. A.; Pentney, R. J.; Rabin, R. A. and others. "Effects of chronic ibogaine treatment on cerebellar Purkinje cells in the rat.", Brain Research, (1997), 759(2), 306-308. PDF (349 KB)

Helsley, Scott; Rabin, Richard A. and Winter, J. C. "The effects of noribogaine and harmaline in rats trained with ibogaine as a discriminative stimulus.", Life Sciences, (1997), 60(9), PL147-PL153. PDF (645 KB)

Hider, C. L. "Rapid identification of frequently abused drugs.", Journal of the Forensic Science Society, (1971), 11(4), 257-262.

Hoelen, D. W. M.; Spiering, W. and Valk, G. D. "Long-QT Syndrome Induced by the Antiaddiction Drug Ibogaine", The New England Journal of Medicine, (2009), 360(3), 308-309. PDF (305 KB)

Hofmann, Albert. "Structure and synthesis of hallucinogens.", Svensk Farmaceutisk Tidskrift, (1971), 75(22), 933-940 (Swedish).

Hough, Lindsay B.; Pearl, Sandra M. and Glick, Stanley D. "Tissue distribution of ibogaine after intraperitoneal and subcutaneous administration.", Life Sciences, (1996), 58(7), PL119-122. PDF (348 KB)

House, Robert V.; Thomas, Peter T. and Bhargava, Hemendra N. "Comparison of the hallucinogenic indole alkaloids ibogaine and harmaline for potential immunomodulatory activity.", Pharmacology, (June 1995), 51(1), 56-65. PDF (1.1 MB)

Hwang, Bruce; Weisbach, Jerry A.; Douglas, Bryce; Raffauf, Robert F.; Cava, Michael P. and Bessho, Kiyoshi. "The alkaloids of Peschiera lundii (D. C.) Miers. Isolation and structure elucidation of voacristine pseudoindoxyl and iboxygaine hydroxyindolenine.", Journal of Organic Chemistry, (1969), 34(2), 412-415. PDF (667 KB)

Ito, Kazuo. "Ibogenine and related basic substances.", Gifu Yakka Daigaku Kiyo, (1961), 11, 9-28.

Jacobson, A. E. "Biological evaluation of compounds for their physical dependence potential and abuse liability. XIII. Drug testing program of the Committee on Problems of Drug Dependence, Inc.", NIDA Research Monograph, (1990), 95, 563.

Jane, I.; McKinnon, A. and Flanagan, R. J. "High-performance liquid chromatographic analysis of basic drugs on silica columns using non-aqueous ionic eluents. II. Application of UV, fluorescence and electrochemical oxidation detection.", Journal of Chromatography, (1985), 323(2), 191-225.

Janot, Maurice-Marie and Goutarel, Robert. "Derivatves of the ibogaine alkaloids.", Unites States patent, (November 19, 1957), 2,813,873. PDF (316 KB)

Janot, Maurice-Marie and Goutarel, Robert. "Alcaloides des Voacanga: Voacamine et vobtusine.", Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences, (1955), 240, 1719-1720 (French). PDF (246 KB)

Janot, Maurice-M.; Goutarel, R. and Sneeden, R. P. A. "Ibogaine.", Helvetica Chimica Acta, (1951), 34, 1205-1207 (French).

Janot, Maurice-Marie and Chaigneau, Marcel. "[Sublimation of alkaloids under reduced pressure.]", Comptes Rendus, (1947), 225, 1371-1373 (French). PDF (468 KB)

Japp, Margaret; Gill, Richard and Osselton, M. David. "Comparison of drug retention indexes determined on packed, wide bore capillary and narrow bore capillary columns.", Journal of Forensic Sciences, (1987), 32(6), 1574-1586.

Jenks, Christopher W. "Extraction Studies of Tabernanthe Iboga and Voacanga Africana.", Natural Product Letters, (2002), 16(1), 71-76. PDF (402 KB)

Jenks, Christopher W. "Iboga Extraction Manual.", Self Published, (2009), 14 pages. English PDF (475 KB), French PDF (507 KB), Portugese PDF (1.3 MB)

Jenks, Christopher W. "Analysis of Iboga and Voacanga Bark and Extracts by HPLC.", Self Published, (2014), 27 pages. PDF (1.0 MB)

Jenks, Christopher W. "Voacanga Extraction Manual: Phase 1: Isolation of Total Alkaloids.", Self Published, (2015), 12 pages. PDF (520 KB), Pictures.

Jenks, Christopher W. "Voacanga Extraction Manual: Phase 2: Separation of voacangine from more basic alkaloids.", Self Published, (2015), 15 pages. PDF (5.0 MB), Pictures.

Jenks, Christopher W. "Voacanga Extraction Manual: Phase 3: Final purification of voacangine." Self Published, (2015), 16 pages. PDF (4.6 MB), Pictures.

Jenks, Christopher W. "Voacanga Extraction Manual: Phase 4: Production and Purification of Ibogaine.", Self Published, (2015), 26 pages. PDF (1.8 MB), Pictures.

Jenks, Christopher W. "Voacanga africana extraction sequence using dilute hydrochloric acid", Self Published, (2020), 3 pages. PDF (44 KB).

Jetter, Alexis. "The psychedelic cure. (using ibogaine to treat drug addiction).", New York Times, (Sunday, April 10, 1994), p50.

Jones, Stacy J. "Use of ibogaine to fight addiction. (patent no. 4,587,243).", New York Times, (Saturday, May 10, 1986), 135(19N), 37(L).

Judd, B. "Ibogaine, psychotherapy, and the treatment of substance-related disorders.", Eighth International Conference on Drug Related Harm, (1994).

Jules, Oswald; Scypinski, Stephen and Love, L. J. Cline. "Fluorescence enhancement of several hallucinogenic drugs in cyclodextrin media.", Analytica Chimica Acta, (1985), 169, 355-360.

Kan, Christiane; Henriques, Amelia; Jasor, Yves; Moretti, Christian and Husson, Henri-Philippe. "[Indole alkaloids from Stenosolen heterophyllus: tabernamine and isotabernamine.]", Journal of Natural Products, (1984), 47(3), 478-481 (French). PDF (490 KB)

Kaplan, C. D; Ketzer, E; de Jong, J. and de Vries, M. "Reaching a state of wellness: Multistage explorations in social neuroscience.", Social Neuroscience Bulletin, (1993), 6(1), 6-7.

Keefner, S. M. and Glick, S. D. "Ibogaine antagonism of morphine-induced hyperactivity: enhancement by prior morphine exposure and role of kappa opioid receptors.", Society of Neuroscience Abstracts, (1994), 20, 502.5.

Kelley, J. M. and Adamson, R. H. "A comparison of common interatomic distances in serotonin and some hallucinogenic drugs.", Pharmacology, (1973), 10, 28-31. PDF (510 KB)

Kesner, Raymond P.; Jackson-Smith, Pamela; Henry, Clarissa and Amann, Kelly. "Effects of ibogaine on sensory-motor function, activity, and spatial learning in rats.", Pharmacology Biochemistry and Behavior, (May 1995), 51(1), 103-109. PDF (837 KB)

Khasawneh, I. M.; Garcia Alvarez-Coque, M. C.; Ramis Ramos, G. and Winefordner, J. D. "Low- and room-temperature phosphorescence characteristics of some pharmaceutical compounds.", Journal of Pharmaceutical and Biomedical Analysis, (1989), 7(1), 29-38.

Kingston, D.; Gerhart, B.; Ionescu, F.; Mangino, M. and Sami, S. "Plant anticancer agents V: New bisindole alkaloids from Tabernaemontana johnstonii stem bark.", Journal of Pharmaceutical Sciences, (1978), 67(2), 249-251. PDF (1.0 MB)

Kingston, D.; Li, B. and Ionescu, F. "Plant anticancer agents III: Isolation of indole and bisindole alkaloids from Tabernaemontana holstii roots.", Journal of Pharmaceutical Sciences, (1977), 6(8), 1135-1138. PDF (1.6 MB)

Knox, John R. and Slobbe, Jacob. "Indole alkaloids from Ervatamia orientalis. I. Isolation of alkaloids and structural identification of two dimers.", Australian Journal of Chemistry, (1975), 28(8), 1813-1823. PDF (2.0 MB)

Kontrimaviciute, V.; Mathieu, O.; Mathieu-Daude, J-C.; Vainauskas, P.; Casper, T.; Baccino, E. and Bressolle, F. "Distribution of Ibogaine and Noribogaine in a Man Following Poisoning Involving Root Bark of the Tabernanthe iboga Shrub.", Journal of Analytical Toxicology, (2006), 30, 434-440. PDF (8.2 MB)

Kostowski, W.; Rewerski, W. and Piechocki, T. "Effects of some hallucinogens on aggressiveness of mice and rats. II.", Pharmacology, (1972), 7(4), 259-263.

Kusumoto, Ines Tomoco; Hattori, Masao; Miyaichi, Yukinori; Tomimori, Tsuyoshi; Hanaoka, Miyoji and Namba Tsuneo. "Effects of flavonoids and alkaloids on reverse transcriptase.", Shoyakugaku Zasshi, (1991), 45(3), 240-254.

Ladhar, F. and Damak, M. "Contribution a l'etude des Tabernaemontanees americaines. III. Alcaloides de Anartia cf. meyeri.", Journal of Natural Products, (1981), 44(4), 459-465 (French). PDF (1.5 MB)

Lambin, Suzanna and Bernard, Jacqueline. "Action of alkaloids on bacteria.", Annales de l'Institut Pasteur, (1953), 85, 757-773.

Lavaud, C. and Massiot, G. "The Iboga Alkaloids.", Progress in the Chemistry of Organic Natural Products, (2017), 105, 89-136. PDF (1.8 MB)

Layer, Richard T.; Skolnick, Phil; Bertha, Craig M.; Bandarage, Upul K.; Kuehne, Martin E. and Popik, Piotr. "Structurally modified ibogaine analogs exhibit differing affinities for NMDA receptors.", European Journal of Pharmacology, (1996), 309(2), 159-165. PDF (939 KB)

Le Men, Jean; Le Men-Oliver, Louisette; Levy, Jean; Levy-Appert-Colin, Marie C. and Hannart, Jean. "N-Substituted indole compounds, dihydroindole derivatives, and indole compounds.", German patent, (September 26, 1974), 2,410,651 (German).

Le Men, Jean; Le Men-Olivier, Mrs.; Levy, Jean; Appert-Collin-Levy, Marie C. and Hannart, Jean. "N-Substituted indole compounds and dihydroindole and N-substituted dihydroindole derivatives.", Belgian patent, (July 2, 1973), 796,521.

Le Men-Olivier, L.; Richard, B. and Le Men, J. "Alcaloides des graines du Pandaca retusa.", Phytochemical Reports, (1974), 13, 280-281 (French). PDF (154 KB)

Le Men-Olivier, Louisette M. T.; Levy, Jean; Levy-Appert-Collin, Marie C.; Hannart, Jean and Le Men, Jean. "Derivatives of iboga alkaloids.", German patent, (May 15, 1975), 2,450,188 (German).

Leal, Mirna Bainy; Michelin, Ka´tia; Souza, Diogo Onofre Souza and Elisabetsky, Elaine. "Ibogaine attenuation of morphine withdrawal in mice: role of glutamate N-methyl-D-aspartate receptors.", Progress in Neuro-Psychopharmacology & Biological Psychiatry, (2003), 27, 781-785. PDF (171 KB)

Lepri, L.; Desideri, P. G. and Lepori, M. "Chromatographic behavior of alkaloids on thin layers of cation exchangers. II. Alginic acid, Rexyn 102, Dowex 50-X4 and sodium carboxymethylcellulose.", Journal of Chromatography, (1976), 123(1), 175-184.

Lerner, Melvin and Katsiaficas, Mary D. "Analytical separations of mixtures of hallucinogenic drugs.", Bulletin on Narcotics, (1969), 21(1), 47-51.

Levi, M. S.; Khan, M. O. F. and Borne, R. F. "Solution-Phase Parallel Synthesis of N,6-Disubstituted Isoquinuclidines as Ibogaine Analogs", Letters in Drug Design & Discovery, (2005), 2, 51-54. PDF (37 KB)

Levy, M. C.; Debray, M.-M.; Le Men-Olivier, L. and Le Men, J. "[Alkaloids of Pandaca speciosa.]", Phytochemistry, (1975), 14(2), 579-580 (French). PDF (241 KB)

Ley, F. Robert; Jeffcoat, A. Robert and Thomas, Brian F. "Determination of ibogaine in plasma by gas chromatography-chemical ionization mass spectrometry.", Journal of Chromatography A, (February 2, 1996), 723(1), 101-109. PDF (958 KB)

Lloyd, H. A.; Fales, H. M.; Highet, P. F.; VandenHeuuel, W. J. A. and Wildman, W. C. "Separation of alkaloids by gas chromatography.", Journal of the American Chemical Society, (1960), 82, 3791.

Long, R. and Lessin, A. W. "Inhibition of 5-hydroxytryptamine uptake by platelets in vitro and in vivo.", The Biochemical Journal, (1962), 82, 4P-5P.

Lotsof, Howard S. "Ibogaine in the treatment of chemical dependence disorders: clinical perspectives.", Bulletin of the Multidisciplinary Association for Psychedelic Studies, (1995), 5(3), 16-27.

Lotsof, Howard S. "Rapid method for interrupting or attenuating poly-drug dependency syndromes.", Unites States patent, (1992), 5,152,994. PDF (423 KB)

Lotsof, Howard S. "Rapid method for interrupting or attenuating the nicotine/tobacco dependency syndrome.", Unites States patent, (1991), 5,026,697. PDF (359 KB)

Lotsof, Howard S. "Rapid method for attenuating the alcohol dependency syndrome.", United States patent, (1989), 4,857,523. PDF (455 KB)

Lotsof, Howard S. "Rapid method for interrupting the cocaine and amphetamine abuse syndrome.", United States patent, (1986), 4,587,243. PDF (421 KB)

Lotsof, Howard S. "Rapid method for interrupting the narcotic addiction syndrome.", United States patent, (1985), 4,499,096. PDF (426 KB)

Love, L. J. Cline; Grayeski, Mary Lynn; Noroski, Joyce and Weinberger, Robert. "Room-temperature phosphorescence, sensitized phosphorescence and fluorescence of licit and illicit drugs enhanced by organized media.", Analytica Chimica Acta, (1985), 170(1), 3-12.

Lu, Lin; Liu, Yanli; Zhu, Weili; Shi, Jie; Liu, Yu; Ling, Walter and Kosten, Thomas R. "Traditional Medicine in the Treatment of Drug Addiciton.", The American Journal of Drug and Alcohol Abuse, (2009), 35, 1-11. PDF (465 KB)

Luxton, T.; Parker, L. A. and Siegel, S. "Ibogaine fails to interrupt the expression of a previously established one-trial morphine place preference.", Progress in Neuro-Psychopharmacology and Biological Psychiatry, (1996), 20(5), 857-872.

Maas, J. and Strubelt, S. "Fatalities after taking ibogaine in addiction treatment could be related to sudden cardiac death caused by autonomic dysfunction", Medical Hypotheses, (2006), 67, 960-964. PDF (91 KB)

Mach, R. H.; Smith, C. R. and Childers, S. R. "Ibogaine possesses a selective affinity for sigma(2) receptors.", Life Sciences, (June 16, 1995), 57(4), PL57-62.

Maisonneuve, I. M.; Mann, G. L.; Deibel, C. R. and Glick, S. D. "Ibogaine and the dopaminergic response to nicotine.", Psychopharmacology, (1997), 129(3), 249-256. PDF (952 KB)

Maisonneuve, I. M. and Glick, S. D. "Interactions between ibogaine and cocaine in rats: in vivo microdialysis and motor behavior.", European Journal of Pharmacology, (1992), 212, 263-266. PDF (410 KB)

Maisonneuve, I. M.; Keller, R. W. Jr. and Glick, S. D. "Interactions of ibogaine and D-amphetamine: in vivo microdialysis and motor behavior in rats.", Brain Research, (1992), 579, 87-92. PDF (690 KB)

Maisonneuve, I. M.; Rossman, K. L.; Keller, R. W. Jr. and Glick, S. D. "Acute and prolonged effects of ibogaine on brain dopamine metabolism and morphine-induced locomotor activity in rats.", Brain Research, (1992), 575, 69-73. PDF (538 KB)

Maisonneuve, Isabelle Marie. "Ibogaine and brain dopamine systems: interactions with drugs of abuse (morphine, amphetamine, cocaine).", Dissertation Abstracts International. B, Science and Engineering. (1992), 52(11), 5773.

Maisonneuve, I. M.; Keller, R. W. Jr. and Glick, S. D. "Interactions between ibogaine, a potential anti-addictive agent, and morphine: an in vivo microdialysis study.", European Journal of Pharmacology, (1991), 199, 35-42. PDF (889 KB)

Mandrile, Eloy L. and Bongiorno de Pfirter, Graciela M. "Natural active principles with hallucinogenic effects. VI. Ibogaine. Its presence in Tabernanthe iboga Baill. H. Bn. (Apocynaceae).", Acta Farmaceutisk Bonaerense, (1985), 4(1), 49-64 (Spanish).

Mash, D. C. "Ibogaine therapy", Addictions - New approaches to Treatment, (2005), S322. PDF (124 KB)

Mash, Deborah C.; Staley, Julie K.; Baumann, Michael H.; Rothman, Richard B. and Hearn, W. L. "Identification of a primary metabolite of ibogaine that targets serotonin transporters and elevates serotonin.", Life Sciences, (June 9, 1995), 57(3), PL45-PL50.

Mash, D. C.; Staley, J. K.; Pablo, J. P.; Holohean, A. M.; Hackman, J. C. and Davidoff, R. A. "Properties of ibogaine and its principal metabolite (12-hydroxyibogamine) at the MK-801 binding site of the NMDA receptor complex.", Neuroscience Letters, (1995), 192(1), 53-56.

Mash, D. C.; Douyon, R.; Hearn, W. L.; Sambol, N. C. and Sanchez-Ramos, J. "A preliminary report on the safety and pharmacokinetics of ibogaine.", Biological Psychiatry, (1995), 37, 652.

Matwyshyn, G. A. and Bhargava, H. N. "Effect of ibogaine on morphine and U 50,488H induced analgesia and hypothermia in the mouse.", FASEB Journal, (1996), 10, 2618.

Meyer, W.; Coppola, J. and Goldman, L. "Alkaloid studies VIII: Isolation and characterization of alkaloids of Tabernaemontana heyneana Wall and antifertility properties of coronaridine.", Journal of Pharmaceutical Sciences, (1973), 62(7), 1199-1201. PDF (1.1 MB)

Milani, B. "[On the pharmacologic action of Tabernanthe Iboga. Collective review and clinical contribution].", Rassegna di Studi Psichiatrici, (1965), 54(2), 185-198 (Italian).

Miller, Greg. "FDA advisers OK human testing of hallucinogen (Food and Drug Administration Drug Abuse Advisory Committee allows testing of ibogaine).", Los Angeles Times, (Thursday, August 26, 1993), 112, A15, col 1.

Molinari, H. H.; Maisonneuve, I. M. and Glick, S. D. "Ibogaine neurotoxicity: a re-evaluation.", Brain Research, (1996), 737(1-2), 255-262. PDF (963 KB)

Molinari, H. H.; Maisonneuve, I. M. and Glick, S. D. "Dose dependence of ibogaine neurotoxicity.", Society for Neuroscience Abstracts, (1994), 20, 504.4.

Moroz, Isabella; Parker, Linda A. and Siegel, Shepard. "Ibogaine interferes with the establishment of amphetamine place preference learning.", Experimental & Clinical Psychopharmacology, (1997), 5(2), 119-122.

Mulamba, T.; Delaude, C.; Le Men-Oliver, L. and Levy, J. "Alcaloides de Tabernanthe pubescens.", Journal of Natural Products, (1981), 44(2), 184-189 (French). PDF (881 KB)

Musumarra, Giuseppe; Scarlata, Giuseppe; Romano, Guido; Clementi, Sergio and Wold, Svante. "Application of principal components analysis to TLC data for 596 basic and neutral drugs in four eluent systems.", Journal of Chromatographic Science, (1984), 22(12), 538-547.

Nadis, Steve. "The mystery of ibogaine: can an African psychedelic cure addiction?", Omni, (July 1993), 15(9), 14. PDF (133 KB)

Naranjo, C. "The Healing Journey.", Pantheon Books, Div. Random House, NY, (1973), 174-228.

Naranjo, C. "Psychotherapeutic possibilities: New fantasy enhancing drugs.", Clinical Toxicology, (1969), 2(2), 209-224.

Nelson, D. L.; Herbert, A.; Petillot, Y.; Pichat, L.; Glowinski, J. and Hamon, M. "[3H]Harmaline as a specific ligand of MAO A. I. Properties of the active site of MAO A from rat and bovine brains.", Journal of Neurochemistry, (1979), 32(6), 1817-1827.

Neuss, Norbert. "Alkaloids from Apocyanaceae. II. Ibogaline, a new alkaloid from Tabernanthe iboga Baill.", Journal of Organic Chemistry, (1959), 24, 2047-2048. PDF (380 KB)

Nielsen, Helene B.; Hazell, Alan; Hazell, Rita; Ghia, Felipe and Torssell, Kurt B. G. "Indole alkaloids and terpenoids from Tabernaemontana markgrafiana.", Phytochemistry, (1994), 37(6), 1729-1735. PDF (970 KB)

O'Callaghan, James P.; Rogers, Tina S.; Rodman, Larry E. and Page, John G. "Acute and chronic administration of ibogaine to the rat results in astrogliosis that is not confined to the cerebellar vermis.", Annals of the New York Academy of Sciences, (1996), 801, 205-216. PDF (650 KB)

O'Hearn, E.; Zhang, P. and Molliver, M. E. "Excitotoxic insult due to ibogaine leads to delayed induction of neuronal NOS in purkinje cells.", Neuroreport, (August 21, 1995), 6(12), 1611-1616.

O'Hearn, E.; Long, D. B. and Molliver, M. E. "Ibogaine induces glial activation in parasagittal zones of the cerebellum.", Neuropharmacology and Neurotoxicology, (1993), NeuroReport 4, 299-302.

O'Hearn, E. and Molliver, M. E. "Degeneration of purkinje cells in parasagittal zones of the cerebellar vermis after treatment with ibogaine or harmaline.", Neuroscience, (1993), 55(2), 303-310. PDF (1.2 MB)

Omnium Chimique, S. A. "Oxidation derivatives of alkaloids.", Belgian patent, (February 15, 1974), 806,438.

Onwere, I.; Chakrabarti, A.; Ali, S. F. and Onaivi, E. S. "Effect of ibogaine on cocaine withdrawal anxiogenesis in mice.", FASEB Journal, (1996), 10, 2595.

Ott, Jonathan. "Pharmacotheon: entheogenic drugs, their plant sources and history.", Kennewick, WA: Natural Products Co., (1993), 371-373. PDF (629 KB)

Palumbo, Patricia A. and Winter, J. C. "Stimulus effects of ibogaine in rats trained with yohimbine, DOM, or LSD.", Pharmacology Biochemistry and Behavior, (December 1992), 43(4), 1221-1226. PDF (776 KB)

Panas, J. M.; Richard, B.; Potron, C.; Razafindrambao, R.; Debray, M-M.; Le Men-Olivier, L. and Le Men, J. "Alcaloides du Muntafara sessilifolia.", Phytochemistry, (1975), 14, 1120-1122 (French). PDF (324 KB)

Panas, J. M.; Richard, B.; Sigaut, C.; Debray, M.-M.; Le Men-Olivier, L. and Le Men, J. "[Alkaloids of Pandaca ochrascens.]", Phytochemistry, (1974), 13(9), 1969-1974 (French). PDF (769 KB)

Paris, Rene and Vairel, Claude. "The effect of iboga and ibogaine on the muscle chronaxia.", Comptes Rendus, (1949), 228, 436-438.

Parker, Linda A. and Siegel, Shepard. "Ibogaine interferes with the establishment of conditioned taste avoidance produced by morphine and lithium.", Learning and Motivation, (1996), 27(2), 170-178.

Parker, Linda A.; Siegel, Shepard and Luxton, Tracey. "Ibogaine attenuates morphine-induced conditioned place preference.", Experimental & Clinical Psychopharmacology, (November 1995), 3(4), 344-348.

Passarella, D.; Barilli, A.; Efange, S. M. N.; Elisabetsky, E.; Leal, M. B.; Lesma, G.; Linck, V. M.; Mash, D. C.; Martinelli, M.; Peretto, I.; Silvani, A. and Danieli, B. "Nature-inspired indolyl-2-azabicyclo[2.2.2]oct-7-ene derivatives as promising agents for the attenuation of withdrawal symptoms: synthesis of 20-desethyl-20-hydroxymethyl-11-demethoxyibogaine", Natural Product Research, (2006), 20(8), 758-765. PDF (275 KB)

Patel, Mahendra B.; Miet, Christine and Poisson, Jacques. "Alkaloids from some African Tabernaemontana.", Annales Pharmaceutiques Francaises, (1967), 25(5), 379-384 (French).

Pearl, S. M.; Hough, L. B.; Boyd, D. L. and Glick, S. D. "Sex differences in ibogaine antagonism of morphine-induced locomotor activity and in ibogaine brain levels and metabolism.", Pharmacology, Biochemistry and Behavior, (1997), 57(4), 809-815. PDF (882 KB)

Pearl, S. M.; Maisonneuve, I. M. and Glick, S. D. "Prior morphine exposure enhances ibogaine antagonism of morphine-induced dopamine release in rats.", Neuropharmacology, (1996), 35(12), 1779-1784.

Pearl, S. M.; Johnson, D. W. and Glick, S. D. "Prior morphine exposure enhances ibogaine antagonism of morphine induced locomotor stimulation.", Psychopharmacology, (October 1995), 121(4), 470-475.

Pearl, Sandra. M.; Herrick-Davis, Katherine.; Teitler, Milton. and Glick, Stanley. D. "Radioligand-binding study of noribogaine, a likely metabolite of ibogaine.", Brain Research, (March 27, 1995), 675(1-2), 342-344. PDF (223 KB)

Pecher, R. H. Martin; Defay, N.; Kaisin, M; Peeters, J. and Van Binst, G. "Indole alkaloids. Presence of N(alpha)-CH group in voachalotine.", Tetrahedron Letters, (1961), 270-273.

Percheron, Francois. "Some alkaloids of Iboga and of Voacanga (Apocynaces).", Annales de Chimie, (1959), 4, 303-364 (French).

Percheron, Francois; Goutarel, Robert and Conreur, Christiane. "Characterization of methyl and ethyl side chains by the method of Kuhn-Roth.", Bulletin de la Societe Chimique de France, (1957), 1198-1200.

Percheron, Francois; Le Hir, Alain; Goutarel, Robert and Janot, Maurice Marie. "'Ibogaine' and 'voacangine'.", Comptes Rendus, (1957), 245, 1141-1143.

Picot, F.; Boiteau, P.; Das, B. and Potier, P. "Alcaloides de Pandaca retusa.", Phytochemistry, (1973), 12, 2517-2519 (French). PDF (230 KB)

Pope, H. G. Jr. "Tabernanthe iboga: An African narcotic plant of social importance", Economic Botany, (1969), 23, 174-184.

Popik, Piotr and Glick, Stanley D. "Ibogaine: a putatively anti-addictive alkaloid.", Drugs of the Future, (1996), 21(11), 1109-1115.

Popik, P. "Facilitation of memory retrieval by the 'anti-addictive' alkaloid, ibogaine.", Life Sciences, (1996), 59(24), PL379-PL385.

Popik, Piotr; Layer, Richard T.; Fossom, Linda H.; Benveniste, Morris; Geter-Douglass, B.; Witkin, J. M. and Skolnick, P. "NMDA antagonist properties of the putative antiaddictive drug ibogaine.", Journal of Pharmacology and Experimental Therapeutics, (November 1995), 275(2), 753-760.

Popik, Piotr; Layer, Richard T. and Skolnick, Phil. "100 Years of ibogaine - neurochemical and pharmacological actions of a putative anti-addictive drug.", Pharmacological Reviews, (1995), 47(2), 235-253.

Popik, P.; Layer, R. T. and Skolnick, P. "The Putative anti-addictive drug ibogaine is a competitive inhibitor of [3H]MK-801 binding to the NMDA receptor complex.", Psychopharmacology, (1994), 114, 672-674.

Quirin, F.; Debray, M.-M.; Sigaut, C.; Thepenier, P.; Le Men-Olivier, L. and Le Men, J. "[Alkaloids of Pandaca eusepala.]", Phytochemistry, (1975), 14(3), 812-813 (French). PDF (246 KB)

Rabin, R. A. and Winter, J. C. "Ibogaine and noribogaine potentiate the inhibition of adenylyl cyclase activity by opioid and 5-HT receptors.", European Journal of Pharmacology, (1996), 316(2-3), 343-348.

Rabin, R. A. and Winter, J. C. "Effects of ibogaine and noribogaine on phosphoinositide hydrolysis.", Brain Research, (1996), 731(1-2), 226-229.

Rahman, Atta-ur; Fatima, Talat; Nisa, Mehrun; Ijaz, S.; Crank, George and Wasti, Shaheen. "Indole alkaloids from Trachelospermum jasminoides.", Planta Medica, (1987), 53, 57-59.

Rapoport, Henry. The Alkaloids of Tabernanthe iboga., (1953).

Raymond-Hamet; Vincent, D. and Parant, M. "Action of some sympathicosthenic alkaloids on cholinesterases.", Comptes Rendus des Seances de la Societe de Biologie, (1956), 150, 1384-1386.

Raymond-Hamet. "Interpretation of the ultraviolet absorption curves of ibogaine and tabernanthine.", Comptes Rendus, (1949), 229, 1359-1361.

Raymond-Hamet. "Sympathicosthenic action of ibogaine on the vessels of the dog's paw.", Comptes Rendus, (1946), 223, 757-759.

Raymond-Hamet. "Some color reactions of ibogaine.", Bulletin de la Societe de Chimie Biologique, (1943), 25, 205-210.

Raymond-Hamet. "Ibogaine.", Bulletin de la Societe Chimique de France, (1942), 9, 620-622.

Raymond-Hamet. "Pharmacologic antagonism.", Comptes Rendus, (1941), 212, 768-771.

Raymond-Hamet. "Mediate and immediate effects of ibogaine on the intestine.", Comptes Rendus des Seances de la Societe de Biologie, (1941), 135, 176-179.

Raymond-Hamet. "Ibogaine and ephedrine.", Comptes Rendus des Seances de la Societe de Biologie, (1940), 134, 541-544.

Raymond-Hamet. "Difference between the physiological action of ibogaine and that of cocaine.", Comptes Rendus, (1940), 211, 285-288. PDF (276 KB)

Raymond-Hamet. "Two physiological properties common to ibogaine and cocaine.", Comptes Rendus des Seances de la Societe de Biologie, (1940), 133, 426-429. PDF (217 KB)

Raymond-Hamet and Rothlin, E. "Pharmacological action of ibogaine.", Archives Internationales de Pharmacodynamie, (1939), 63, 27-39.

Reid, M. S.; Hsu, K.; Souza, K. H.; Broderick, P. A. and Berger, S. P. "Neuropharmacological characterization of local ibogaine effects on dopamine release.", Journal of Neural Transmission, (1996), 103(8-9), 967-985.

Reio, L. "Third supplement for the paper chromatographic separation and identification of phenol derivatives and related compounds of biochemical interest using a 'reference system'.", Journal of Chromatography, (1970), 47(1), 60-85.

Renner, U. and Prins, D. A. "[Voacanga alkaloids. III. Voacristine: its identity to voacangarine and degradation to iboxygaine and ibogaine.]", Experientia, (1959), 15(12), 456-457 (German). PDF (334 KB)

Renner, U.; Prins, D. A. and Stoll, W. G. "[Alkaloids from Conopharyngia durissima Stapf. Isovoacangine, conopharyngine, conodurine, and conoduramine.]", Helvetica Chimica Acta, (1959), 42(5), 1572-1581 (German). PDF (1.4 MB)

Repke, David B.; Artis, Dean R.; Nelson, Janis T. and Wong, Erik H. F. "Abbreviated ibogaine congeners. Synthesis and reactions of tropan-3-yl-2- and -3-indoles. Investigation of an unusual isomerization of 2-substituted indoles using computational and spectroscopic techniques.", Journal of Organic Chemistry, (April 22, 1994), 59(8), 2164-2171. PDF (1.2 MB)

Rezvani, A. H.; Overstreet, D. H. and Leef, Y. W. "Attenuation of alcohol intake by ibogaine in three strains of alcohol-preferring rats.", Pharmacology Biochemistry and Behavior, (November 1995), 52(3), 615-620.

Richard, B.; Delaude, C.; Massiot, G. and Le Men-Oliver, L. "Alkaloids from Voacanga schweinfurthii var. Puberula.", Journal of Natural Products, (1983), 46(2), 283-284. PDF (292 KB)

Rolland, Yves; Croquelois, Guy; Kunesch, Nicole; Boiteau, Pierre; Debray, Maurice; Pecher, Jacques and Poisson, Jacques. "[Alkaloids of the leaves of Voacanga thouarsii.]", Phytochemistry, (1973), 12(8), 2039-2042 (French). PDF (706 KB)

Rosenmund, Peter; Haase, Wolfgang H.; Bauer, Juergen and Frische, Rainer. "[Contributions to the chemistry of indole, VII. Syntheses in the Iboga-Series, III. Ibogamine, ibogaine, and epiibogamine.]", Chemische Berichte, (1975), 108(6), 1871-1895 (German). PDF (3.1 MB)

Rothlin, E. and Raymond-Hamet. "Effect of ibogaine on the isolated rabbit uterus.", Comptes Rendus des Seances de la Societe de Biologie, (1938), 127, 592-594.

Rothlin, E. and Raymond-Hamet. "Action of ibogaine (ibogine) on the isolated seminal vesicle of the rabbit.", Comptes Rendus des Seances de la Societe de Biologie, (1934), 116, 1340-1342.

Sallay, Stephen I. "The total synthesis of dl-ibogamine.", Journal of the American Chemical Society, (December 6, 1967), 89(25), 6762-6763. PDF (280 KB)

Sallay, Stephen I. "An approach to the synthesis of ibogaine.", Tetrahedron Letters, (1964), 36, 2443-2450. PDF (433 KB)

Salmoiraghi, Gian Carlo and Page, Irvine H. "Effects of lysergic acid diethylamide (LSD 25), 2-bromolysergic acid diethylamide (BOL 148), bufotenine, mescaline, and ibogaine on the potentiation of hexobarbital hypnosis produced by serotonin and reserpine.", Journal of Pharmacology and Experimental Therapeutics, (1957), 120, 20-25.

Sanchez-Ramos, J. and Mash, D. C. "Ibogaine research update: Phase I human study.", Bulletin of the Multidisciplinary Association for Psychedelic Studies, (1994), 4(4), 11.

Scallet, A. C.; Ye, X.; Rountree, R.; Nony, P. and Ali, S. F. "Ibogaine produces neurodegeneration in rat, but not mouse, cerebellum. Neurohistological biomarkers of Purkinje cell loss.", Annals of the New York Academy of Sciences, (1996), 801, 217-226.

Scallet, A. C.; Ye, X. and Ali, S. F. "NOS and fos in rat and mouse brain regions. Possible relation to ibogaine-induced Purkinje cell loss.", Annals of the New York Academy of Sciences, (1996), 801, 227-238.

Scallet, A. C.; Ye, X.; Rountree, R. L.; Schmued, L. C. and Ati, S. F. "Ibogaine, a putative treatment for drug-addiction -neuropathology in rats and mice.", Brain Pathology, (1996), 6, 356.

Schechter, Martin D. "Serotonergic mediation of fenfluramine discriminative stimuli in fawn-hooded rats.", Life Sciences, (1997), 60(6), PL83-PL90. PDF (827 KB)

Schechter, Martin D. and Gordon, Timothy L. "Comparison of the behavioral effects of ibogaine from three sources: mediation of discriminative activity.", European Journal of Pharmacology, (November 2, 1993), 249(1), 79-84. PDF (767 KB)

Schechter, Martin D. "Cocaine discrimination is attenuated by isradipine and CGS 10746B.", Pharmacology Biochemistry and Behavior, (March 1993), 44(3), 661-664. PDF (546 KB)

Schleiffer, H. (Ed.) "Narcotic plants of the old world: An anthology of texts from ancient times to the present.", Lubrecht & Cramer, Monticello, NY,.(1979).

Schlittler, E.; Burckhardt, C. A. and Gellert, E. "[Fusion of ibogaine with potassium hydroxide.]", Helvetica Chimica Acta, (1953), 36(6), 1337-1344 (German). PDF (831 KB)

Schmid, P. B. "[The psychic effect of ibogaline hydrochloride (alkaloid from Tabernanthe iboga Baill)].", Arzneimittel-Forschung, (April 1967), 17(4), 485-490 (German). PDF (882 KB)

Schmued, L. C.; Albertson, C. and Slikker, W. Jr. "Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration.", Brain Research, (1997), 751(1), 37-46. PDF (1.1 MB)

Schneider, A. S.; Nagel, J. E. and Mah, S. J. "Ibogaine selectively inhibits nicotinic receptor-mediated catecholamine release.", European Journal of Pharmacology, (1996), 317(2-3), R1-R2.

Schneider, Jurg Adolf. "Tabernanthine, ibogaine containing analgesic compositions.", United States patent, (December 24, 1957), 2,817,623. PDF (388 KB)

Schneider, Jurg A. and Rinehart, Roy A. "Analysis of the cardiovascular action of ibogaine hydrochloride.", Archives Internationales de Pharmacodynamie, (1957), 110, 92-102.

Schneider, J. A. and Sigg, E. B. "Neuropharmacological studies on ibogaine, an indole alkaloid with central-stimulant properties.", Annals New York Academy of Sciences, (1957), 66, 765-776.

Schneider, J. A. and McArthur, Marie. "Potentiating action of ibogaine (Bogadin TM) on morphine analgesia.", Experientia, (1956), 12(8), 323-324.

Schultes, Richard Evans and Hofmann, Albert. "The Botany and Chemistry of Hallucinogens, 2nd ed.", C. C. Thomas, Springfield, IL, (1980), 233-240.

Scott, A. I. and Wei, C. C. "Regio- and stereospecific models for the biosynthesis of the indole alkaloids. The Aspidosperma-Iboga relationship.", Journal of the American Chemical Society, (1972), 94(23), 8266-8267.

Scott, A. I. and Qureshi, A. A. "Biogenesis of Strychnos, Aspidosperma, and Iboga alkaloids. The structure and reactions of preakuammicine.", Journal of the American Chemical Society, (1969), 91(21), 5874-5876. PDF (330 KB)

Seltzmann, H. H.; Odear, D. F.; Laudeman, C. P.; Carroll, F. I. and others. "Metallation/reduction as a new approach to tritium labelling - the synthesis of [H-3]ibogaine.", Journal of Labelled Compounds & Radiopharmaceuticals, (April 1994), 34(4), 367-375.

Seltzman, Herbert H.; Odear, Denise F.; Carroll, F. Ivy and Wyrick, Christopher D. "A new approach to tritium labelling; the synthesis of [3H]ibogaine.", Journal of the Chemical Society-Chemical Communications, (December 15, 1992), 24, 1757-1758.

Sershen, Henry; Hashim, Audrey and Lajtha, Abel. "Ibogaine and cocaine abuse: Pharmacological interactions at dopamine and serotonin receptors.", Brain Research Bulletin, (1997), 42(3), 161-168. PDF (1.1 MB)

Sershen, Henry; Hashim, Audrey and Lajtha, Abel. "The effect of ibogaine on sigma- and NMDA-receptor-mediated release of [3H]dopamine.", Brain Research Bulletin, (1996), 40(1), 63-67.

Sershen, H.; Hashim, A. and Lajtha, A. "The effect of ibogaine on sigma- and NMDA-receptor mediated release of (3H) dopamine.", Journal of Neurochemistry, (1996), 66, S59. PDF (278 KB)

Sershen, Henry; Hashim, Audrey and Lajtha, Abel. "Effect of ibogaine on cocaine-induced efflux of [3H]dopamine and [3H]serotonin from mouse striatum.", Pharmacology Biochemistry and Behavior, (April 1996), 53(4), 863-869. PDF (830 KB)

Sershen, Henry; Hashim, Audrey and Lajtha, Abel. "The effect of ibogaine on kappa-opioid- and 5-HT3-induced changes in stimulation-evoked dopamine release in vitro from striatum of C57BL/6By mice.", Brain Research Bulletin, (1995), 36(6), 587-591. PDF (567 KB)

Sershen, Henry; Hashim, Audrey and Lajtha, Abel. "Effect of ibogaine on serotonergic and dopaminergic interactions in striatum from mice and rats.", Neurochemical Research, (1994), 19(11), 1463-1466. PDF (538 KB)

Sershen, H.; Hashim, A. and Lajtha, A. "Ibogaine reduces preference for cocaine consumption in C57BL/6By mice.", Pharmacology Biochemistry and Behavior, (January 1994), 47(1), 13-19.

Sershen, H.; Hashim, A. and Lajtha, A. "Ibogaine reduces preference for cocaine consumption in C57BL/6By mice.", Pharmacology Biochemistry and Behavior, (1993), 46, 942-948.

Sershen, H.; Harsing, L. G. Jr.; Hashim, A. and Lajtha, A. "Ibogaine reduces amphe locomotor in C57L/6By mice, but stimulates locomotor activity in rats.", Life Sciences, (1992), 51, 1003-1011.

Sershen, H.; Hashim, A.; Harsing, L. G. Jr. and Lajtha, A. "Ibogaine antagonizes cocaine induced locomotor stimulation in mice.", Life Sciences, (1992), 50, 1079-1086.

Shamma, M. and Soyster, H. E. "Rates of methiodide formation and the stereochemistry of the ethyl side chain of Iboga type alkaloids.", Experientia, (January 15, 1964), 20(1), 36-38.

Sharpe, L. G. and Jaffe, J. H. "Ibogaine fails to reduce naloxone-precipitated withdrawal in the morphine dependent rat.", NIDA Research Monograph, (1991), 105, 477.

Sharpe, L. G. and Jaffe, J. H. "Ibogaine fails to reduce naloxone-precipitated withdrawal in the morphine-dependent rat.", Neuropharmacology and Neurotoxicology, (1990), 1, 17-19.

Shen, Tsung-Ying. "Medicinal chemical studies of anti-inflammatory and analgesic natural products.", Journal of the Chinese Chemical Society, (1995), 42, 617-621. PDF (552 KB)

Sheppard, Simon G. "A preliminary investigation of ibogaine: case reports and recommendations for further study.", Journal of Substance Abuse Treatment, (1994), 11(4), 379-385. PDF (811 KB)

Siek, T. J. "Identification of drugs and other toxic compounds from their ultraviolet spectra. I. Ultraviolet absorption properties of sixteen structural groups.", Journal of Forensic Sciences, (1974), 19(2), 193-214.

Singbartl, G.; Zetler, G. and Schlosser, Lucie. "Structure-activity relationships of intracerebrally injected tremorigenic indole alkaloids.", Neorupharmacology, (1973), 12(3), 239-244. PDF (734 KB)

Singbartl, G.; Zetler, G. and Schlosser, Lucie. "Pharmacokinetic studies on structure-activity relationship of tremor-producing harmala and iboga alkaloids.", Naunyn-Schmiedeberg's Archives of Pharmacology, (1972), 274, R109. PDF (126 KB)

Sisko, B. "Interrupting drug dependency with ibogaine: a summary of four case histories.", Bulletin of the Multidisciplinary Association for Psychedelic Studies, (1993), 4(2), 15-24.

Sloviter, Robert S.; Drust, Eugene G.; Damiano, Bruce P. and Connor, John D. "A common mechanism for lysergic acid, indolealkylamine and phenethylamine hallucinogens: serotonergic mediation of behavioral effects in rats.", The Journal of Pharmacology and Experimental Therapeutics, (1980), 214(2), 231-238. PDF (1.2 MB)

Smith, C. M. and Abood, L. G. "The action of some CNS [central nervous system] and local anesthetic drugs on the stimulated glycolysis of frog sartorius muscle.", International Journal of Neuropharmacology, (1966), 5(3), 255-261.

Soriano-Garcia, M. "Structure of ibogaine.", Acta Crystallographica Section C-Crystal Structure Communications, (November 15, 1992), 48, 2055-2057. PDF (538 KB)

Stafford, Peter. "Psychedelics Encyclopedia", Ronin Publishing Inc., Berkeley, CA, (1992), 358-367.

Staley, Julie K.; Ouyang, Qinjie; Pablo, John; Hearn, W. Lee; Flynn, Donna D.; Rothman, Richard B.; Rice, Kenner C. and Mash, Deborah C. "Pharmacological screen for activities of 12-hydroxyibogamine: a primary metabolite of the indole alkaloid ibogaine.", Psychopharmacology, (1996), 127(1), 10-18. PDF (1.2 MB)

Stauffacher, D. and Seebeck, E. "[Voacangerine, a new alkaloid from Voacanga africana Stapf.]", Helvetica Chimica Acta, (1958), 41(1), 169-180. PDF (1.6 MB)

Sweetnam, P. M.; Lancaster, J.; Snowman, Adele; Collins, J. L. and others. "Receptor binding profile suggests multiple mechanisms of action are responsible for ibogaine's putative anti-addictive activity.", Psychopharmacology, (April 1995), 118(4), 369-376.

Talapatra, S. K.; Sen Gupta, S.; Bhattacharya, M. and Talapatra, B. "Alkaloids of Tabernaemontana wallichiana.", Indian Journal of Chemistry, Section B: Organic Chemistry, Including Medicinal Chemistry, (1976), 14B(5), 385-387. PDF (465 KB)

Tatevosyan, G. T. "Alkaloids of the ibogaine group.", U Spekhi Khim., (1959), 28, 990-1010.

Taub, Eric. "Free at last - ibogaine, the African connection", Magical Blend, (April 1995), 46, 31-36.

Taylor, W. I. "The Iboga and Voacanga alkaloids.", The Alkaloids, Chemistry and Physiology, Akademic Press, New York , (1968), 11, 79-98.

Taylor, W. I. "The Iboga and Voacanga alkaloids.", The Alkaloids, Chemistry and Physiology, R. H. F. Manske, Ed: Academic Press, New York, (1965), Volume 8, 203-235. PDF (3.4 MB)

Taylor, William Irving. "Process for the manufacture of indoles and products obtained thereby.", United States patent, (March 10, 1959), 2,877,229. PDF (536 KB)

Taylor, W. I. "The biogenesis of the Tabernanthe iboga alkaloids.", Experientia, (1957), 13, 454.

Taylor, W. I. "Iboga alkaloids. II. Structures of ibogaine, ibogamine, and tabernanthine.", Journal of the American Chemical Society, (1957), 79, 3298-3299.

Thomas, David. W. and Biemann, K. "The alkaloids of Voacanga africana.", Lloydia, (1968), 31(1), 1-8.

Thomas, J. and Starmer, G. "The isolation and identification of the major alkaloid present in Tabernaemontana pachysiphon Stapf. var cumminsi (Stapf.) H. Huber.", Journal of Pharmacy and Pharmacology, (1963), 15, 487. PDF (249 KB)

Touchette, Nancy. "Anti-addiction drug ibogaine on trial.", Nature Medicine, (April 1995), 1(4), 288-289.

Tuomisto, J.; Walaszek, E. J. and Pazdernik, T. L. "Inhibition of histamine uptake in platelets by alkaloids.", Annales Medicinae Experimentalis et Biologiae Fenniae, (1973), 51(2), 59-64.

Turner, Wm. J.; Merles, Sidney and Carl, Ann. "Concerning theories of indoles in schizophrenigenesis.", American Journal of Psychiatry, (1955), 112, 466-467. PDF (291 KB)

Valette, G. and Leclair, M. F. "[The effect of alkaloids from Tabernanthe iboga H. Bn. on the response of isolated organs to catecholamines and the possible role of calcium exchange. Case of Ibogaine].", Comptes Rendus Hebdomadaires des Seances de L Academie des Sciences. D: Sciences Naturelles, (October 31, 1977), 285(11), 1147-1150 (French).

Valette, G. and Leclair, M. F. "[Effects of Tabernanthe iboga H. Bn. alkaloids on the isolated organ responses to catecholamines and the role of calcium exchanges. Tabernanthine].", Comptes Rendus Hebdomadaires des Seances de L Academie des Sciences. D: Sciences Naturelles, (September 19, 1977), 285(5), 591-594 (French).

van Beek, T. A.; de Smidt, C. and Verpoorte, R. "Phytochemical investigation of Tabernaemontana crassa.", Journal of Ethnopharmacology, (1985), 14(2-3), 315-318. PDF (260 KB)

van Beek, T. A.; Verpoorte, R.; Svendsen, A. Baerheim; Leeuwenberg, A. J. M. and Bisset, N. G. "Tabernaemontana L. (Apocynaceae): A review of its taxonomy, phytochemistry, ethnobotany and pharmacology.", Journal of Ethnopharmacology, (1984), 10(1), 1-156. PDF (8.4 MB)

van Beek, T. A.; Verpoorte, R. and Baerheim Svendsen, A. "Identification of Tabernaemontana alkaloids by means of thin-layer chromatography and chromogenic reactions.", Journal of Chromatography, (1984), 298(2), 289-307.

van Beek, T. A. "Pharmacognostical studies of some Tabernaemontana species.", Ph. D. Dissertation, Rijksuniversiteit Leiden, (1984), 161p.

van Beek, T. A.; Verpoorte, R. and Svendsen, A. "Alkaloids from Tabernaemontana psorocarpa.", Planta Medica, (1983), 47, 83-86. PDF (1.4 MB)

van Binst, G.; Dewaersegger, L. and Martin, Richard Henri. "Application of gas-phase chromatography to the study of products of pyrolysis of indole alkaloids. II. Interpretation of the pyrograms, and discussion.", Journal of Chromatography, (1966), 25(1), 15-28 (French).

van Binst, G.; Danheux, C. and Martin, R. H. "Studies of models of indole alkaloids. IV. Solvent effect in infrared and NMR spectroscopy of methoxy derivatives of 1,2,3,4-tetrahydrocarbazole.", Bulletin des Societes Chimiques Belges, (1966), 75(3-4), 181-190.

van Binst, G.; Danheux, C.; Hootele, C.; Pecher, J. and Martin, R. H. "Physicochemical studies of models of indole alkaloids. II. Nuclear magnetic resonance of methoxytetrahydrocarbazoles.", Tetrahedron Letters, (1964), 17-18, 973-981 (French).

van Binst, G.; Denolin-Dewaersegger, L. and Martin, R. H. "Application of gas phase chromatography to the study of products of pyrolysis of indole alkaloids. I. Obtaining the pyrogram.", Journal of Chromatography (1964), 16(1), 34-39 (French).

van der Heyden, Peter. "Synthesis of Ibogaine Hydrochloride", PsyGen (self published), (2022). PDF (154 KB)

Vastag, B. "Ibogaine Therapy: A 'Vast Uncontrolled Experiment'", Science, (2005), 308, 345-346. PDF (259 KB)

Vincent, D. and Lagren, R. "Tonic drugs for muscle, defatiguing drugs and cholinesterases.", Congres des Societes Savantes de Paris et des Departments, Comptes Rendus, (1953), 563-569.

Vincent, D. and Lagreu, R. "The cholinesterase of the pancreas: its behavior in presence of some inhibitors in comparison with the cholinesterases of serum and brain.", Bulletin de la Societe de Chimie Biologique, (1949), 31, 1043-1045.

Vincent, D. and Beaujard, P. "Detection of cholinesterase-inhibiting alkaloids (primarily eserine). Toxicological applications.", Annales Pharmaceutiques Francaises, (1945), 3, 22-26.

Vincent, D. and Sero, I. "Inhibiting action of Tabernanthe iboga on serum cholinesterase.", Comptes Rendus des Seances de la Societe de Biologie, (1942), 136, 612-614.

Vinson, J. A. and Hooyman, J. E. "Laboratory-use reagents. II. Universal thin- layer chromatographic visualization reagents for drugs.", Journal of Chromatography, (1975), 105(2), 415-417.

Vinson, J. A.; Hooyman, J. E. and Ward, C. E. "Identification of street drugs by thin-layer chromatography and a single visualization reagent.", Journal of Forensic Sciences, (1975), 20(3), 552-556.

Vocci, F. J. and London, E. D. "Assessment of neurotoxicity from potential medications for drug abuse: ibogaine testing and brain imaging.", Annals of the New York Academy of Sciences, (1997), 820, 29-40. PDF (919 KB)

Walaszek, E. J.; Huggins, C. G. and Smith, C. M. "Drugs that modify actions of pharmacologically active polypeptides.", Annals of the New York Academy of Sciences, (1963), 104(Article 1), 281-289.

Walls, F.; Collera, O. and L., Sandoval A. "Alkaloids from Stemmadenia species-I. The alkaloids of S. Donnell-Smithii and S. Galleottiana.", Tetrahedron, (1958), 2, 173-182. PDF (1.3 MB)

Warren, R. J.; Eisdorfer, I. B.; Thompson, W. E. and Zarembo, J. E. "Infrared identification of indole ring in indoles and indole alkaloids in the 400- to 700- /cm region.", Journal of Pharmaceutical Sciences, (1965), 54(12), 1806-1807.

Warthen, John David Jr. "Synthesis of analogs of ibogaine.", Dissertation Abstracts International. B, Science and Engineering., (1966), 27(4), 1107-1108. PDF (460 KB)

Wenkert, Ernest; Cochran, David W.; Gottlieb, Hugo E. and Hagaman, Edward W. "13C-NMR. Spectroscopy of naturally occurring substances. XLV. Iboga alkaloids.", Helvetica Chimica Acta, (November 3, 1976), 59(7), 2437-2442. PDF (626 KB)

Whitaker, Patricia M. and Seeman, Philip. "Selective labeling of serotonin receptors by d-[3H]-lysergic acid diethylamide in calf caudate.", Proceedings of the National Academy of Sciences of the United States of America , (1978), 75(12), 5783-5387.

Whitaker, Patricia M. and Seeman, Philip. "High-affinity 3H-serotonin binding to caudate: inhibition by hallucinogens and serotoninergic drugs.", Psychopharmacology [Berlin], (1978), 59(1), 1-5.

Whitaker, Patricia M. and Seeman, Philip. "Hallucinogen binding to dopamine/neuroleptic receptors.", Journal of Pharmacy and Pharmacology, (1977), 29(8), 506-507.

Witkin, J. M.; Brave, S.; French, D. and Geter-Douglass, B. "Discriminative stimulus effects of R-(+)-3-amino-1-hydroxypyrrolid-2-one, [(+)-HA-966], a partial agonist of the strychnine-insensitive modulatory site of the N-methyl-D-aspartate receptor.", Journal of Pharmacology and Experimental Therapeutics, (December 1995), 275(3), 1267-1273.

Woods, J. H.; France, C. P.; Medzihradsky, F.; Smith, C. B. and Winger, G. D. "Evaluation of new compounds for opioid activity, 1992. [Review].", NIDA Research Monograph, (1993), 132, 517-578.

Woods, J. H.; Medzihdsky, F.; Smith, C. B.; Winger, G. D. and Franc, C. P. "1989 Annual report, evaluation of new compounds for opioid activity.", NIDA Research Monographs, (1990), 95, 563,607,655-656.

Yamazaki, Mikio and Leete, Edward. "Biosynthesis of the iboga alkaloids. Incorporation of tryptophan-3-14C into ibogaine.", Tetrahedron Letters, (1964), 23-24, 1499-1501.

Zetler, G. "Cholecystokinin octapeptide (CCK-8), ceruletide and analogues of ceruletide: effects on tremors induced by oxotremorine, harmine and ibogaine. A comparison with prolyl-leucylglycine amide (MIF), anti-Parkinsonian drugs and clonazepam.", Neuropharmacology, (June 1983), 22(6), 757-766. PDF (1.3 MB)

Zetler, G.; Singbartl, G. and Schlosser, Lucie. "Cerebral pharmacokinetics of tremor-producing harmala and iboga alkaloids.", Pharmacology, (1972), 7(4), 237-248. PDF (1.5 MB)

Zetler, Gerhard and Singbartl, G. "Inhibition of cardiac effects of noradrenaline by eleven indole alkaloids, two azepinoindoles, quinidine, quindonium, and propranolol.", Pharmacology, (1970), 4(3), 129-142.

Zetler, G.; Lenschow, E. and Prenger-Berninghoff, W. "[The actions of 11 indole-alkaloids on the guinea pig heart in vivo and in vitro, compared with those of 2 synthetic azepinoindoles, quinidine and quindonium.]", Naunyn Schmiedeberg's Archiv fur Pharmakologie und Experimentelle Pathologie, (1968), 260(1), 26-49 (German). PDF (4.3 MB)

Zetler, G. "[Some pharmacological properties of 12 natural and 11 partially synthetic indole alkaloids from tropical Apocyanaceae of the sub-tribe Tabernaemontaninae.]", Arzneimittel-Forschung, (1964), 14(12), 1277-1286 (German). PDF (1.9 MB)

Zetler, G.; Muller, W. and Warm, I. "Jactatio capitis, a pharmacologically elicited stereotype motor reaction in the mouse.", Naunyn Schmiedeberg's Archiv fur Pharmakologie und Experimentelle Pathologie, (1959), 237, 247-263.

Zetler, G. and Unna, K. R. "Central effects of voacangine, voacamine, voacamidine, voacorine, and ibogaine.", Naunyn Schmiedeberg's Archiv fur Pharmakologie und Experimentelle Pathologie, (1959), 236, 122-123. PDF (655 KB)

Zhu, J.-P., Guggisberg, M. and Hesse, M. "Chemotaxonomic study of the genus Tabernaemontana (Apocynaceae) based on their indole alkaloid content.", Pl. Syst. Evol., (1990), 172, 13 - 34. PDF (1.51 MB)